Neutrophil‐to‐Lymphocyte Ratio as a Predictor for <scp>PD</scp>‐<scp>L1</scp> Inhibitor Treatment in Recurrent or Metastatic Nasopharyngeal Carcinoma
Elevated NLR is strongly associated with lower response to treatment and reduced survival rates in patients with R/M NPC being treated with PD-L1 inhibitors. Patients with high NLR values have poor efficacy and survival.
Authors
- Yiyan Pei (ORCID: https://orcid.org/0000-0003-3293-6236)
- Ping Ai (ORCID: https://orcid.org/0000-0002-0169-0926)
- Zheran Liu (ORCID: https://orcid.org/0000-0002-4848-4951)
- Junyou Ge
- Youneng Wei
- Xingchen Peng (ORCID: https://orcid.org/0000-0001-7042-718X)
- Yan Qing
- Xiang Jin (ORCID: https://orcid.org/0000-0002-3890-5556)
- Ye Chen (ORCID: https://orcid.org/0000-0001-5317-4846)
- Huilin Li (ORCID: https://orcid.org/0000-0002-8288-7068)
- Song Ge (ORCID: https://orcid.org/0000-0003-4172-1704)
- Kun Gao (ORCID: https://orcid.org/0000-0002-8471-3416)
- Zhigong Wei
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
- Kelun Group (China) (CN)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1002/hed.28101
- Citations
- 2
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.09